Century Therapeutics, Inc.

25 North 38^th Street, 11^th Floor
Philadelphia, Pennsylvania 19104

 

February 17, 2026

 

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

100 F Street, N.E.

Washington, D.C. 20549-7553

 

	Re:	Century Therapeutics, Inc.
		Registration Statement on Form S-3
		Filed February 5, 2026, 2026 (File No. 333-293228)

 

Ladies and Gentlemen:

 

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Century Therapeutics, Inc. (the “Company”) hereby requests that the effective date of the Company’s Registration Statement on Form S-3 (File No. 333-293228) (the “Registration Statement”) be accelerated so that the Company’s Registration Statement will become effective at 4:05 P.M., Eastern Time, on January 17, 2026, or as soon thereafter as is practicable.

 

Please contact Jennifer Porter, Esq. of Goodwin Procter LLP, counsel to the Company, at (445) 207-7806 to provide notice of effectiveness, or if you have any questions or comments concerning this request.

 

[Remainder of the page intentionally left blank]

 

 

	Very truly yours,
	CENTURY THERAPEUTICS, INC.
	By:	/s/ Brent Pfeiffenberger, Pharm.D.
		Name:	Brent Pfeiffenberger, Pharm.D.
		Title:	President and Chief Executive Officer